Designing clinical development programs for anti-hepatitis B virus drugs.
Brown
Nathaniel A
NA
Hepatitis Clinical Research, Idenix Pharmaceuticals, Cambridge, MA, USA.
D000998:Antiviral Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D024882:Drug Resistance, Viral; D005838:Genotype; D006509:Hepatitis B / Q000188:drug therapy*; D006514:Hepatitis B Surface Antigens / Q000235:genetics; D006515:Hepatitis B virus / Q000187:drug effects / Q000235:genetics / Q000276:immunology; D006801:Humans; D007372:Interferons / Q000008:administration & dosage / Q000627:therapeutic use*; D019259:Lamivudine / Q000008:administration & dosage / Q000627:therapeutic use*; D012107:Research Design
D000998:Antiviral Agents; D006514:Hepatitis B Surface Antigens; D019259:Lamivudine; D007372:Interferons